Costs & hospitals · patient guide

Non-Small Cell Lung Cancer Care in China: Cost Questions Beyond the First Visit

After a first visit for non-small cell lung cancer in China, ask the treating hospital for a written quote that names the planned treatment, the records it is based on, what is included, what is excluded, what remains undecided, who is paid, and when the quote expires. Without that written scope, no figure is comparable or reliable.

Go to the practical guidance ↓
Editorial illustration: Non-Small Cell Lung Cancer Care in China: Cost Questions Beyond the First Visit
Illustrative image; not a photograph of a named hospital or an identified patient.
In this guide

Why a first-visit figure is not yet a treatment quote

A first consultation for non-small cell lung cancer (NSCLC) often happens before the full clinical picture is settled. The treating team may still be reviewing pathology, biomarker results, staging imaging and any previous cancer therapy. A number mentioned at that stage can be a registration fee, a consultation fee, an estimate for one test, or a provisional range for a plan that has not been finalised. Those are different things, and treating them as the same number is how cost expectations go wrong.

The practical question is not whether a figure was quoted, but what that figure was attached to. Ask the hospital to state, in writing, the clinical plan the figure refers to. If the plan is still being decided, the honest answer is that no treatment quote exists yet. That is not a refusal to discuss cost; it is a boundary between a preliminary indication and a committed scope.

For NSCLC specifically, the treatment route can differ depending on whether the disease is being considered for surgery, radiotherapy, systemic therapy such as targeted treatment or immunotherapy, or a combination. Each route carries different tests, medicines, inpatient or outpatient arrangements and follow-up. A single lump sum quoted before that route is agreed cannot be checked against anything.

So the first useful action after a first visit is to request the written scope, not a lower number. A quote without a named plan, a named record set and a named payer is not a quote you can compare with another hospital or with your home country.

The records that determine what can be quoted

A hospital cannot price a plan it cannot see. For NSCLC, the documents that usually shape the clinical route include the pathology report confirming the cancer type, biomarker or molecular test results where they exist, staging imaging reports, and a record of previous cancer therapy including what was given, when and how the patient responded or did not. Operative notes, discharge summaries and current medication lists also matter.

If some of these are missing, the correct response is to ask which specific documents the hospital needs and to send them, not to assume the hospital will guess. It is also reasonable to ask whether the hospital will accept your existing reports or whether it requires its own repeat tests before it can quote. That answer changes both the scope and the timeline, so it belongs in the written quote discussion.

A useful way to frame the request is: 'Based on the records you have now, what plan are you quoting, and which records are still missing that could change it?' This keeps the conversation on the clinical basis rather than on a number that may not survive the next test result.

Do not send passport numbers, card details or a complete medical archive in a first message. A short summary with the main question is enough to start; the hospital or coordinator can then tell you which records it actually needs.

What a written quote should name

A quote that can be checked has several parts. It should name the planned treatment or treatments, the clinical stage or working diagnosis it is based on, and the date it was prepared. It should state what is included, what is excluded, and what is still undecided. It should say who is paid for each part: the hospital, a pharmacy, a laboratory, or a separate coordination service. It should also state how long the figure holds and what would cause it to change.

For NSCLC, the undecided items are often the ones that move the total most. Whether a targeted therapy or immunotherapy medicine is part of the plan, whether radiotherapy is included, how many cycles or fractions are envisaged, and whether the patient will be admitted or treated as an outpatient are all scope questions. A quote that does not address them is incomplete, not necessarily wrong.

Ask specifically about medicines. Some cancer medicines are hospital-supplied, some are prescribed and dispensed elsewhere, and availability can differ between hospitals. Do not assume a medicine is included because it appears in the plan. Ask the hospital to state, in writing, whether each named medicine is included in its quote, supplied separately, or not yet confirmed.

The same applies to tests. If the plan depends on a repeat biomarker test or a new scan, ask whether that test is inside the quoted scope or will be billed on its own. The answer is provider-specific, so it must come from the hospital handling your case.

Comparing two hospitals without inventing a benchmark

Comparing NSCLC care between hospitals is only meaningful when the scopes match. A figure from one hospital that covers surgery and admission cannot be set against a figure from another that covers only a consultation and a scan. Before comparing, put both quotes side by side against the same checklist: named plan, named records, included items, excluded items, undecided items, payer, and validity period.

Where a hospital will not provide a written scope, that is itself useful information. It does not prove the care is poor, but it means you cannot compare it responsibly. You can ask again, in writing, for the specific items above. If the answer remains a verbal range, treat it as provisional and say so in your own notes.

Be careful with any claim that one hospital is cheaper across the board. Without a written scope, a lower headline figure may simply reflect a narrower plan. The useful comparison is not 'which number is smaller' but 'which written scope matches the treatment my clinicians are considering, and what is left outside it'.

If you are working with a coordination service, keep its fees separate from hospital medical fees. They are different payers and different scopes. Ask for each in writing rather than a combined figure that hides which part is which.

Questions to send the hospital after the first visit

A short, specific message gets a more useful reply than a broad request for 'the cost'. The following questions are designed to produce a written scope you can act on. Send them to the hospital's international office or your named contact, and keep the replies together.

First: 'Which clinical plan is this quote based on, and which records did you use?' Second: 'What is included, what is excluded, and what is still undecided?' Third: 'For each medicine and each test in the plan, is it inside this quote or billed separately, and by whom?' Fourth: 'How long does this figure hold, and what would change it?' Fifth: 'Who is the payee for each part, and how are payments made?'

If the reply is a single number with no scope, ask again for the five items above. If the hospital says the plan is not yet decided, ask what it needs to decide it, and when it expects to be able to quote. That is a legitimate scheduling question, not a demand for a discount.

For NSCLC, add one more: 'If the biomarker or staging picture changes, how would that affect the plan and the quote?' This tells you whether the figure you have is stable or provisional, which matters before you commit to travel.

What to do while the scope is still open

While a hospital is still assembling the plan, you can prepare without committing to a figure. Keep a single folder with the pathology report, biomarker results, staging imaging reports, previous treatment records and current medication list, in English or with a translation. Note which documents are originals and which are copies. This is the same set any hospital will ask for, so assembling it once saves repeated requests.

Do not delay necessary local care while an overseas enquiry is in progress. If symptoms worsen, local assessment takes priority. An overseas cost question is a planning matter, not a reason to postpone urgent treatment.

You can also ask the hospital whether it offers a records-based review before travel, and what that review can and cannot establish. A records-based opinion can clarify the likely options and the records still needed, but it does not by itself confirm hospital acceptance, final eligibility or a fixed treatment plan. Those remain decisions for the treating hospital and its clinicians.

When you are ready, a short initial enquiry is free and does not require buying a proxy consultation. You can send a brief summary of the diagnosis and your main question, and the team can tell you which records to share next and which hospital route may fit. For confirmed lung surgery services, the relevant reference is the lung lobectomy page, which explains that a lobectomy removes one lobe and is different from removing an entire lung. The hospital decides whether any particular procedure is suitable for you.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Oxford University Hospitals: Cardiothoracic Ward

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.